Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

2(40.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04362085Phase 3Completed

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

Role: collaborator

NCT06393608Phase 2Recruiting

Epsom Salt Compresses to Relieve Perineal for Postpartum Care: a Clinical Trial

Role: collaborator

NCT06709703Not ApplicableNot Yet Recruiting

Kinematic Alignment in Total Knee Arthroplasty - a Double-blind Randomised Controlled Trial Between Robotic and Caliper-based Techniques

Role: collaborator

NCT00231803Not ApplicableCompleted

The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

Role: collaborator

NCT01654445Phase 2Completed

TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion

Role: collaborator

NCT02528487Suspended

Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?

Role: collaborator

NCT01247415Unknown

Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine

Role: collaborator

All 7 trials loaded